SNDX SYNDAX PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Appointment of Chief Commercial Officer Syndax Pharmaceuticals announced the appointment of Steven Closter as Chief Commercial Officer, following the voluntary resignation of Steve Sabus.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC